Back to Results

Pharmacom Biovet Inc (PHMB)

PharmaCom BioVet, Inc. is a common stock listing on OTC Markets tied to a healthcare company focused on companion animal cancer care. The company operates a network of treatment centers in the United States and works on procedures such as bone marrow transplantation for animals diagnosed with lymphoma, other cancers, and certain other serious diseases. It also reports licensed proprietary devices and compounds intended to help reduce suffering in animals with cancer. Founded in 1995 and headquartered in Raleigh, North Carolina, the company was formerly known as ABV Gold Inc. before adopting its current name in August 2008.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-PHMB	Not available	Not available	Not available	Good	0.0%	10.784 K

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Healthcare

Industry

Healthcare Providers & Services

Quality & Risk

Financial Health

Good

Valuation • Fair Value

Pharmacom Biovet Inc (OTC-PHMB) Fair Value by Valuation Model

No usable valuation estimate is currently available for Pharmacom Biovet Inc (OTC-PHMB); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Pharmacom Biovet Inc (OTC-PHMB). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Pharmacom Biovet Inc (OTC-PHMB)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Pharmacom Biovet Inc (OTC-PHMB) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Pharmacom Biovet Inc (OTC-PHMB)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Pharmacom Biovet Inc (OTC-PHMB). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Pharmacom Biovet Inc (OTC-PHMB)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Pharmacom Biovet Inc (OTC-PHMB). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Sell

The daily technical read for Pharmacom Biovet Inc (OTC-PHMB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Sell

The weekly technical read for Pharmacom Biovet Inc (OTC-PHMB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Sell

The monthly technical read for Pharmacom Biovet Inc (OTC-PHMB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Pharmacom Biovet Inc (OTC-PHMB) Stock FAQ

Data-supported answers about Pharmacom Biovet Inc (OTC-PHMB), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

Not available

No reliable estimate from the currently supported inputs

Financial Health

Good

Current financial-health read

A reliable fair value estimate is not currently available for Pharmacom Biovet Inc (OTC-PHMB). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Pharmacom Biovet Inc (OTC-PHMB) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Pharmacom Biovet Inc (OTC-PHMB).

The current market capitalization listed for Pharmacom Biovet Inc is 10.784 K.

The ticker symbol for Pharmacom Biovet Inc is OTC-PHMB, and the stock is listed on OTC Markets.

Pharmacom Biovet Inc (OTC-PHMB) is listed on OTC Markets.